CSIMarket
 
Lemaitre Vascular Inc   (NASDAQ: LMAT)
 

Lemaitre Vascular Inc's Suppliers Performance

LMAT's Supply Chain




 
LMAT Costs vs Sales of Suppliers Growth Lemaitre Vascular Inc recorded an increase in cost of sales by 3.25 % year on year, sequentially cost of sales grew by 8.99 % in Q2.

More on LMAT Suppliers



Lemaitre Vascular Inc recorded increase in cost of sales by 3.25 % year on year, sequentially cost of sales grew by 8.99 % in Q2.

More on LMAT Suppliers




Lemaitre Vascular Inc's Comment on Supply Chain


The company processes and cryopreserves human tissue obtained from qualified U.S. tissue procurement organizations that collect donated human tissue from deceased donors. It purchases certain components, outsources some product manufacturing, and contracts third parties for product sterilization. While most components are sourced from multiple suppliers, some key components depend on single or limited suppliers without contractual agreements, with orders placed as needed. The company has not experienced significant supply disruptions. Its manufacturing facilities in Burlington and North Brunswick hold ISO 13485 certification, and the Fox River Grove facility is accredited by the American Association of Tissue Banks for cardiac and vascular tissue processing, storage, and distribution. All facilities are subject to periodic regulatory inspections and audits.

Lemaitre Vascular Inc's Comment on Supply Chain


The company processes and cryopreserves human tissue obtained from qualified U.S. tissue procurement organizations that collect donated human tissue from deceased donors. It purchases certain components, outsources some product manufacturing, and contracts third parties for product sterilization. While most components are sourced from multiple suppliers, some key components depend on single or limited suppliers without contractual agreements, with orders placed as needed. The company has not experienced significant supply disruptions. Its manufacturing facilities in Burlington and North Brunswick hold ISO 13485 certification, and the Fox River Grove facility is accredited by the American Association of Tissue Banks for cardiac and vascular tissue processing, storage, and distribution. All facilities are subject to periodic regulatory inspections and audits.







LMAT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Lemaitre Vascular Inc 1,970.82 262.92 67.68 655
SUBTOTAL 0.00 0.00 0.00 -


Sources: Lemaitre Vascular Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Lemaitre Vascular Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.